Main Menu

Our Work

Alleged anticompetitive conduct in generic pharmaceuticals market

Serving as lead consulting expert for the plaintiffs in a matter involving a pharmaceutical manufacturer that allegedly engaged in anticompetitive conduct resulting in the branded drug continuing to maintain majority market share despite the availability of generic substitutes.

Jump to Page

We use cookies to optimize the performance of this site and give you the best user experience. By clicking "Accept," you agree to our use of cookies.

Necessary Cookies

Necessary cookies enable core functionality such as security, network management, and accessibility. You may disable these by changing your browser settings, but this may affect how the website functions.

Analytical Cookies

Analytical cookies help us improve our website by collecting and reporting information on its usage. We access and process information from these cookies at an aggregate level.